Have a personal or library account? Click to login
Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way Cover

Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way

Acta Pharmaceutica
Volume 70 (2020): Issue 2 (June 2020)
By: Katja Berginc,  Nadica Sibinovska,  Simon Žakelj,  Jurij Trontelj and  Igor Legen  
Open Access
|Jan 2020

Authors

Katja Berginc

katja.berginc@sandoz.com

Ljubljana, Slovenia

Nadica Sibinovska

Ljubljana, Slovenia
University of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics, Ljubljana, Slovenia

Simon Žakelj

University of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics, Ljubljana, Slovenia

Jurij Trontelj

University of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics, Ljubljana, Slovenia

Igor Legen

Ljubljana, Slovenia
DOI: https://doi.org/10.2478/acph-2020-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 131 - 144
Accepted on: May 31, 2019
|
Published on: Jan 16, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
desloratadine,
BCS-based bio-waiver,
luminal stability,
permeability,
dissolution
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Katja Berginc, Nadica Sibinovska, Simon Žakelj, Jurij Trontelj, Igor Legen, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 70 (2020): Issue 2 (June 2020)Next article